"The Addiction Institute of Mount Sinai and Center on Addiction Forge Strategic Alliance to Improve Addiction Treatment"
More than 3 million young Americans between the ages of 12 and 25 suffer from drug addiction. Overdose deaths among young people are on the rise. To address this devastating problem, the Addiction Institute of Mount Sinai and Center on Addiction formed a strategic alliance that will invest in innovative solutions, with a current focus on opioid addiction. Through the collaboration, leading addiction experts will work together to create innovative, scalable models for treatment, which include evidence-based screening, preventative practices, and care specifically tailored to young people with substance use disorders. Eric J. Nestler, MD, PhD, Dean for Academic and Scientific Affairs, Director of The Friedman Brain Institute, and Nash Family Professor of Neuroscience at the Icahn School of Medicine at Mount Sinai states, “Working together, we will draw on the shared goals, experience and expertise of two institutions that have strong reputations for addressing these devastating conditions in both the lab and in the clinic so we may stop the deep suffering so many young people and their families endure." The alliance officially launched on Thursday, October 11, with a kickoff panel discussion and reception at The Mount Sinai Hospital.
- Joseph Plumeri, Trustee, Mount Sinai Health System
- Yasmin Hurd, PhD, Professor, Psychiatry, Neuroscience, Pharmacology, Systems Therapeutics, Icahn School of Medicine at Mount Sinai, Chair, Ward-Coleman Translational Neuroscience, Director of the Center for Addictive Disorders, Mount Sinai Health System
- Eric Nestler, MD, PhD, Dean, Academic and Scientific Affairs, Director, Friedman Brain Institute, Professor, Neuroscience, Pharmacological Sciences, Psychiatry, Icahn School of Medicine at Mount Sinai
Additional Coverage: